title: The scopolamine model of dementia: chronic transdermal administration.
abstract: The transient impairments of memory produced by the muscarinic antagonist scopolamine have been adopted as a pharmacological model of Alzheimer-type dementia in normal volunteers. In this study we examined the effects of chronic (72 h) transdermal administration of scopolamine on memory, attention, sedation and visual function. The transdermal patches provided constant plasma levels of scopolamine for the duration of the study. Indices of the peripheral effects of scopolamine (visual near-point and pupil size) showed impairments that were sustained for 3 days. However, measures of sedation and memory revealed impairments that were maximal the day after patch application and which were no longer present 3 days after application. This pattern of results is discussed in relation to pharmacological modelling of Alzheimer's disease.
authors.affiliation: Neuroscience Research Centre, Merck, Sharp and Dohme, Terlings Park, Eastwick Road, Harlow, Essex, UK.
authors.forename: C
authors.initials: C
authors.lastname: Brazell
authors.forename: G C
authors.initials: GC
authors.lastname: Preston
authors.forename: C
authors.initials: C
authors.lastname: Ward
authors.forename: C R
authors.initials: CR
authors.lastname: Lines
authors.forename: M
authors.initials: M
authors.lastname: Traub